About UCSF Search UCSF UCSF Medical Center

Philip E. LeBoit, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
leboit_philip

Professor, Department of Pathology, UCSF

Phone: (800) 497-0244 (appts)
Box 1790, UCSF
San Francisco, CA 94143-1790

View on UCSF Profiles


Additional Websites


Education

Sarah Lawrence College, Bronxville, NY, A.B., 1971-75, History
Albany Medical College, Albany NY, M.D., 1975-79
Univ. of California San Francisco, CA, Resident, 1979-81, Pathology
Mt. Sinai School of Medicine, New York, Resident, 1981-82, Pathology
New York University, NY (7-12/82) and Cornell Univ. Medical Center, NY (1-6/83), Fellow, 1982-83, Dermatopathology

Professional Experience

  • 1985-86
    Clinical Instructor, Depart. of Pathology, UCSF
  • 1986-91
    Assist. Clin. Professor, Depart. of Pathology, UCSF
  • 1991-97
    Associate Professor of Clinical Pathology, Dept. of Pathol-ogy, UCSF
  • 1997-present
    Professor of Clinical Pathology, Dept. of Pathology, UCSF
  • Ancillary Positions Held Concurrently:
  • 1987-present
    Director, UCSF Dermatopathology Service, UCSF
  • 1989-present
    Director, Fellowship Training Program in Dermatopathology, Depts. of Pathology and Dermatology
  • 1990-present
    Director, Dermatopathology Section, Dept. of Pathology
  • 1997-present
    Professor of Clinical Dermatology, Dept. of Dermatology, UCSF
  • 1997-present
    Editor-in-Chief, The American Journal of Dermatopathology, Lippincott Williams & Wilkins

Honors & Awards

  • 1988
    Certificate of Appreciation, Dept. of Medicine and Surgery, Veterans Administration Medical Center, Martinez, CA
  • 1992
    Honorable Mention, Distinguished Teaching Award, Academic Senate, UCSF
  • 1997
    Teacher of the Year Award, Department of Dermatology, UCSF
  • 2002
    Ackerman Lecture and Award, International Society of Dermatopathology
  • 2002
    Pinkus Lecture and Award, American Society of Dermatopathology
  • 2004
    Founder's Award, American Society of Dermatopathology

Selected Publications

  1. Berliner JG, Haemel A, Leboit PE, Pincus LB. Cover quizlet. J Cutan Pathol. 2013 Nov; 40(11):917.
    View on PubMed
  2. Berliner JG, Haemel A, Leboit PE, Pincus LB. The sarcoidal variant of annular elastolytic granuloma. J Cutan Pathol. 2013 Nov; 40(11):918-20.
    View on PubMed
  3. Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Nov; 26(6):845-51.
    View on PubMed
  4. Wood BA, LeBoit PE. An 'inflammatory' variant of solar purpura: a simulant of leukocytoclastic vasculitis and neutrophilic dermatoses. Pathology. 2013 Aug; 45(5):484-8.
    View on PubMed
  5. Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, Prieto VG, Leboit PE, Barnhill RL, Cooper C, Yazdan P, Guitart J, Liu P, Pestova E, Busam K. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013 May; 37(5):676-84.
    View on PubMed
  6. LeBoit PE. Simulators of cutaneous lymphoma: where should our efforts go? Am J Clin Pathol. 2013 Apr; 139(4):414-7.
    View on PubMed
  7. Posch C, Moslehi H, Feeney L, Green GA, Ebaee A, Feichtenschlager V, Chong K, Peng L, Dimon MT, Phillips T, Daud AI, McCalmont TH, LeBoit PE, Ortiz-Urda S. Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo. Proc Natl Acad Sci U S A. 2013 Mar 5; 110(10):4015-20.
    View on PubMed
  8. North JP, Yeh I, McCalmont TH, LeBoit PE. Melanoma ex blue nevus: two cases resembling large plaque-type blue nevus with subcutaneous cellular nodules. J Cutan Pathol. 2012 Dec; 39(12):1094-9.
    View on PubMed
  9. Sun BK, Saggini A, Sarin KY, Kim J, Benjamin L, LeBoit PE, Khavari PA. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol. 2013 Mar; 133(3):824-7.
    View on PubMed
  10. Yeh I, McCalmont TH, LeBoit PE. Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma. Br J Dermatol. 2012 Nov; 167(5):1106-10.
    View on PubMed
  11. Hope TA, Leboit PE, High WA, Fu Y, Brasch RC. Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model. Magn Reson Imaging. 2013 Jan; 31(1):139-44.
    View on PubMed
  12. Dalton SR, Chandler WM, Abuzeid M, Hossler EW, Ferringer T, Elston DM, LeBoit PE. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages. Am J Dermatopathol. 2012 Aug; 34(6):586-91.
    View on PubMed
  13. North JP, McCalmont TH, LeBoit P. Palmar pits associated with the nevoid basal cell carcinoma syndrome. J Cutan Pathol. 2012 Aug; 39(8):735-8.
    View on PubMed
  14. Leboit PE. What genomics has taught me about melanocytic neoplasms. G Ital Dermatol Venereol. 2012 Jun; 147(3):239-49.
    View on PubMed
  15. Feito-Rodríguez M, de Lucas-Laguna R, Bastian BC, Leboit P, González-Beato MJ, López-Gutiérrez JC, Requena L, Pizarro A. Nodular lesions arising in a large congenital melanocytic naevus in a newborn with eruptive disseminated Spitz naevi. Br J Dermatol. 2011 Nov; 165(5):1138-42.
    View on PubMed
  16. Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, North JP, Vemula SS, Mauro TM, Neuhaus IM, Leboit PE, Hur JS, Park K, Huh N, Kwok PY, Arron ST, Massion PP, Bale AE, Haussler D, Cleaver JE, Gray JW, Spellman PT, South AP, Aster JC, Blacklow SC, Cho RJ. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A. 2011 Oct 25; 108(43):17761-6.
    View on PubMed
  17. Jalas JR, Vemula S, Bezrookove V, Leboit PE, Simko JP, Bastian BC. Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma. Am J Surg Pathol. 2011 Sep; 35(9):1413-8.
    View on PubMed
  18. Girardi M, Kay J, Elston DM, Leboit PE, Abu-Alfa A, Cowper SE. Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol. 2011 Dec; 65(6):1095-1106.e7.
    View on PubMed
  19. Durinck S, Ho C, Wang NJ, Liao W, Jakkula LR, Collisson EA, Pons J, Chan SW, Lam ET, Chu C, Park K, Hong SW, Hur JS, Huh N, Neuhaus IM, Yu SS, Grekin RC, Mauro TM, Cleaver JE, Kwok PY, LeBoit PE, Getz G, Cibulskis K, Aster JC, Huang H, Purdom E, Li J, Bolund L, Arron ST, Gray JW, Spellman PT, Cho RJ. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 2011 Jul; 1(2):137-43.
    View on PubMed
  20. McCalmont TH, LeBoit PE. Polygonal CD34 positivity portends trichilemmal differentiation. J Cutan Pathol. 2010 Sep; 37(9):923, 924-5.
    View on PubMed

Go to UCSF Profiles, powered by CTSI